Preeti Bajaj

Preeti Bajaj is an experienced professional in health economics and outcomes research, currently serving as the Executive Director, Global Health Economics & Outcomes Research at Revolution Medicines since 2025. Prior roles include Senior Director, Head of Global Health Economics & Outcomes Research at Prothena Corporation plc (2023-2025) and various positions at Genentech from 2015 to 2023, such as Team Lead and Principal Health Economist in Health Economics & Outcomes Research. Preeti has expertise in oncology and neuroscience, with specific leadership roles in health economics for breast and ovarian cancers. Additional experience includes consultancy roles at VeriTech and Accenture and research positions at the National Institutes of Health and the Rehabilitation Institute of Chicago. Preeti holds a Ph.D. in Pharmaceutical Outcomes Research and Policy from the University of Washington and a Bachelor's Degree in Biomedical Engineering from The Johns Hopkins University.